نتایج جستجو برای: lymphoproliferative disorders
تعداد نتایج: 674262 فیلتر نتایج به سال:
Chronic myelocytic leukemia (CML) may display a lymphoproliferative phase (lymphoid blast crisis) that is generally of B cell phenotype. Since lymphoproliferative disorders may occur following bone marrow transplantation (BMT), it may be difficult to distinguish posttransplant relapse of CML lymphoid blast crisis from de novo lymphoproliferation. Lymphoid blast crisis cells from a patient with ...
Citation: Saito S, Suzuki K, Yoshimoto K, Kaneko Y, Yamaoka K, Shimizu T, Mori T, Okamoto S, Kameyama K, Amano K, Tamaru J-i, Tokuhira M and Takeuchi T (2018) Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment. Front. Immunol. 9:621. doi: 10.3389/fimmu.2018.00621 restoration of Decrea...
Hematologic malignancies and lymphoproliferative disorders have been reported after using tumor necrosis factor-α inhibitor in patients suffering from spondyloarthropathy. Previously reported cases were treated by using infliximab and etanercept. Usually, it takes approximately several months for leukemia or lymphoproliferative disorders to occur after the application of those agents. However, ...
Introduction As in the acute leukaemias, immunophenotyping has been shown to be useful in the characterisation and classification of the chronic lymphoproliferative disorders.' 2 This term refers to a group of diseases caused by the clonal proliferation of B and T lymphocytes. Recognition of the various disease entities is essential because of major implications for prognosis and patient manage...
The T-cell lymphoproliferative disorders are a heterogeneous group of non-Hodgkin's lymphomas (NHL) for which current therapeutic strategies are inadequate, as most patients afflicted with these NHL will succumb to disease progression within 2 years of diagnosis. Appreciation of the genetic and immunologic landscape of these aggressive NHL, including PD-L1 (B7-H1, CD274) expression by malignant...
OBJECTIVE To study the prevalence of hepatitis C virus in lymphoproliferative disorders. METHODS A case control prospective study was performed on 143 patients with lymphoproliferative disorders and 29 patients with non-hematological malignancies were taken as controls. All the patients in both groups were analyzed for various risk factors for infection with hepatitis C virus and were tested ...
BACKGROUND The variability in the association of host innate immune response to Hepatitis C virus (HCV) infection requires ruling out the possible role of host KIR and HLA genotypes in HCV-related disorders: therefore, we therefore explored the relationships between KIR/HLA genotypes and chronic HCV infection (CHC) as they relate to the risk of HCV-related hepatocarcinoma (HCC) or lymphoprolife...
Lymphoproliferative disorders are a very heterogeneous group of neoplastic diseases, which originate from malignant transformation of cells of the lymphoid system. Within broad limits, they include at least four main types of diseases: Hodgkin’s disease, the socalled non-Hodgkin’s lymphomas, the chronic lymphoid leukemias and the neoplasms of mature B antibody-producing cells, such as Waldenstr...
BACKGROUND Some uncommon lymphoproliferative and histiocytic disorders may present with an aggressive course and require hematopoietic stem cell transplantation (HSCT) as part of the therapeutic approach. METHODS Published research on the use of HSCT for the treatment of these disorders was reviewed and summarized. RESULTS Allogeneic HSCT may be indicated in patients with blastic plasmacyto...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید